MCM
ANIP icon

MAI Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

MAI Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
2,683
+151
+6% +$12.1K ﹤0.01% 1765
2026
Q1 		$195K Buy
2,532
+10
+0.4% +$781 ﹤0.01% 1475
2025
Q4 		$199K Buy
2,522
+22
+0.9% +$1.91K ﹤0.01% 1314
2025
Q3 		$229K Hold
2,500
– – ﹤0.01% 1220
2025
Q2 		$163K Hold
2,500
– – ﹤0.01% 1269
2025
Q1 		$167K Hold
2,500
– – ﹤0.01% 1186
2024
Q4 		$138K Buy
+2,500
New +$144K ﹤0.01% 1293

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MAI Capital Management's ANIP Position: Q2 2026 in Review

MAI Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 6% in Q2 2026, buying an estimated $12.1K and bringing the position to 2,683 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

MAI Capital Management first reported a position in ANIP in Q4 2024 and has held it in 7 quarters since. The position peaked at $229K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • MAI Capital Management held 2,683 shares of ANI Pharmaceuticals worth $222K as of Q2 2026.
  • MAI Capital Management bought 151 ANI Pharmaceuticals shares in Q2 2026, an estimated $12.1K.
  • ANI Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1765 holding.
  • MAI Capital Management first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • MAI Capital Management's ANI Pharmaceuticals position peaked at $229K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.